Rosacea
Conditions
Interventions
Group 1 :Minocycline capsule
Group 2:Minocycline capsules combined with 630nm LED light
Group 3:Minocycline Capsules Combine 630nm and 590nm LED Light
Group 4:Minocycline Capsules Combine 630nm and 450nm LED Light
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Patients with clinically diagnosed papulopustular rosacea according to the 2002 NRSEC diagnostic criteria. (2) Men and women who are at least 18 years of age. (3) Consistent use of Winona Soothing Moisturizing Special Cream and application of sunscreen with SPF>30 daily during the study period. (4) Those who have signed informed consent and are willing to complete this study.
Exclusion criteria
Exclusion criteria: (1) Rhinophyma or ocular rosacea. (2) Persons who are allergic to light. (3) Persons who have taken oral retinoids or other photosensitizing drugs within 1 month. (4) Pregnant, expectant or breastfeeding women. (5) Those who have used other methods of treatment in the 1 month prior to the study. (6) Patients with severe systemic, neoplastic or immunodeficiency diseases. (7) Those with serious neurological or psychiatric illnesses. (8) Those who cannot be assured that no other treatment will be used during the study. (9) Staff members who participated in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of symptom severity ; | — |
Countries
China
Contacts
Public ContactXian Jiang
West China Hospital, Sichuan University
Outcome results
None listed